Paper Details

Paper Title

High body mass index is associated with increased risk of treatment failure and surgery in biologic-treated patients with ulcerative colitis.

Paper Journal Title

Aliment Pharmacol Ther

Paper Citation Count

Paper Publication Year

2018

Bio Mention

IBD, UC, adalimumab, certolizumab pegol, golimumab, infliximab, obesity, patients, ulcerative colitis, vedolizumab

Mesh Descriptor

Author Name	Affiliation
Nghia H Nguyen	University of California San Diego
James A Proudfoot	Altman Clinical and Translational Research Institute, University of California San Diego
Parambir S Dulai	University of California San Diego
Brigid S Boland	University of California San Diego
Brigid S Boland	University of California San Diego
Eduardo Grunvald	University of California San Diego
Amir Zarrinpar	University of California San Diego
Amir Zarrinpar
Amir Zarrinpar	Institute for Diabetes and Metabolic Health, University of California San Diego
William J Sandborn	University of California San Diego
Siddharth Singh	University of California San Diego
Siddharth Singh	University of California San Diego

Column Actions